LPCN
Lipocine Inc.
stockNASDAQ
lipocine inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. the company develops drugs based on hydroance, a drug delivery technology. it primarily focuses on developing oral versions of several hormones for use in men and women health. the company's lipid-based technology platform offers non-invasive delivery solutions for small polar organics and macromolecules. it also offers custom drugs for pharmaceutical/biotechnology companies. lipocine inc. was founded in 1997 and is headquartered in salt lake city, utah.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.09 | 2026-09-28 | -1.91% | -4.349 |
| 1M | 2.45 | 2026-09-04 | -16.33% | 1.484 |
| 3M | 2.47 | 2026-07-06 | -17.00% | 1.254 |
| 6M | 1.94 | 2026-04-06 | +5.67% | 1.553 |
| 1Y | 3.35 | 2025-10-03 | -38.81% | 1.391 |
| 2Y | 4.66 | 2024-10-04 | -56.01% | — |
| 5Y | 17.68 | 2021-10-04 | -88.41% | 0.792 |
Lipocine Inc. (NASDAQ:LPCN) stock price today is $2.05, and today's volume is 38,941. LPCN is down 0.966% today. The 30 day average volume is 35,461. LPCN market cap is $16.90M with 8.24M shares outstanding.